Skip to content
10-Q

Quarterly Report

IONIS PHARMACEUTICALS, INC. IONS

0000874015-26-000177

← back to feed
Filed
Apr 29, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 23, 2026 165.26M sh
Shares Diluted Q1 2026 · Mar 31, 2026 164.87M sh
Shares Diluted Q1 2026 · Mar 31, 2025 158.74M sh
Capex Q1 2026 · Mar 31, 2026 $21.76M
Capex Q1 2026 · Mar 31, 2025 $12.58M
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$792.82M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$150.78M
Short Term Investments Q1 2026 · Mar 31, 2026 $1.75B
Short Term Investments Q1 2026 · Dec 31, 2025 $2.31B
Cash And Equivalents Q1 2026 · Mar 31, 2026 $173.38M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $372.26M
Stockholders Equity Q1 2026 · Mar 31, 2026 $491.41M
Stockholders Equity Q1 2026 · Dec 31, 2025 $489.09M
Stockholders Equity Q1 2026 · Mar 31, 2025 $475.73M
Stockholders Equity Q1 2026 · Dec 31, 2024 $588.35M
Current Liabilities Q1 2026 · Mar 31, 2026 $716.59M
Current Liabilities Q1 2026 · Dec 31, 2025 $781.57M
Total Liabilities Q1 2026 · Mar 31, 2026 $2.96B
Total Liabilities Q1 2026 · Dec 31, 2025 $3.03B
Current Assets Q1 2026 · Mar 31, 2026 $2.94B
Current Assets Q1 2026 · Dec 31, 2025 $2.99B
Total Assets Q1 2026 · Mar 31, 2026 $3.45B
Total Assets Q1 2026 · Dec 31, 2025 $3.52B
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.56
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.93
Eps Basic Q1 2026 · Mar 31, 2026 −$0.56
Eps Basic Q1 2026 · Mar 31, 2025 −$0.93
Sga Expense Q1 2026 · Mar 31, 2026 $150.36M
Sga Expense Q1 2026 · Mar 31, 2025 $76.25M
Net Income Q1 2026 · Mar 31, 2026 −$92.53M
Net Income Q1 2026 · Mar 31, 2025 −$146.94M
Operating Income Q1 2026 · Mar 31, 2026 −$117.42M
Operating Income Q1 2026 · Mar 31, 2025 −$146.86M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $2.98M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $1.46M
Revenue Q1 2026 · Mar 31, 2026 $246.09M
Revenue Q1 2026 · Mar 31, 2025 $131.61M